SPR Therapeutics Announces First Use of SPRINT endura Peripheral Nerve Stimulation System to treat Complex Regional Pain Syndrome
15 nov. 2018 08h00 HE
|
SPR Therapeutics, Inc.
SPRINT System is the least invasive PNS device for CRPS CLEVELAND, Nov. 15, 2018 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today...
SPR Therapeutics Awarded $10M From U.S. Department of Defense
02 oct. 2018 10h30 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Oct. 02, 2018 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, has been awarded two new grants and one new contract from the U.S....
SPR Therapeutics Announces First Use of SPRINT extensa Dual-lead Peripheral Nerve Stimulation System to Treat Low Back Pain
25 sept. 2018 10h10 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Sept. 25, 2018 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced that Christopher Gilmore, MD of Carolinas Pain...
FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management
16 août 2018 08h30 HE
|
SPR Therapeutics, Inc.
SPRINT® is the First and Only Dual Lead Capable PNS Platform Company also provides first look at 12-month durability outcomes following 60-day SPRINT therapy CLEVELAND, Aug. 16, 2018 (GLOBE...
SPR Therapeutics® Secures $25 Million in Series C Financing
12 sept. 2017 08h03 HE
|
SPR Therapeutics, LLC
CLEVELAND, Sept. 12, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., (SPR) a private medical device company that has developed a novel neurostimulation technology for chronic and acute pain,...
SPR Therapeutics Promotes Dr. Joseph Boggs to SVP of Research and Development
07 sept. 2017 09h13 HE
|
SPR Therapeutics, LLC
CLEVELAND, Sept. 07, 2017 (GLOBE NEWSWIRE) -- SPR® Therapeutics, LLC (SPR), a private medical device company that has developed a novel, evidence-based neurostimulation platform for chronic and...
Opioid Concerns and Work Interference Cited as Top Reasons to Delay Knee Replacement Surgery
03 août 2017 11h03 HE
|
SPR Therapeutics, LLC
CLEVELAND, Ohio, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Patients in need of a total knee replacement (TKR) often delay surgery by two or more years because of concerns about the duration of postoperative...
SPR Therapeutics Awarded $6M Contract From the United States Department of Defense to Advance Non-Opioid Pain Relief Therapy
15 mai 2017 09h03 HE
|
SPR Therapeutics, LLC
CLEVELAND, May 15, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics (SPR) has been awarded a $6M four-year contract from the U.S. Department of Defense (DoD) to further advance its SPRINT™ Peripheral Nerve...
SPR Therapeutics Appoints Michael P. Chuisano to Board of Directors
21 mars 2017 09h33 HE
|
SPR Therapeutics, LLC
CLEVELAND, March 21, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, LLC, a private medical device company that has developed a novel, evidence-based neurostimulation platform for chronic and acute pain,...
Les C. Vinney Named 2016 NACD Top 100 Directors
19 janv. 2017 09h30 HE
|
SPR Therapeutics, LLC
CLEVELAND, Jan. 19, 2017 (GLOBE NEWSWIRE) -- The National Association of Corporate Directors (NACD) has named SPR® Therapeutics’ Board Member, Les C. Vinney, one of the top 100 most influential...